270 related articles for article (PubMed ID: 34890277)
1. Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy.
Seth R; McKinnon TAJ; Zhang XF
Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H87-H93. PubMed ID: 34890277
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.
Katneni UK; Alexaki A; Hunt RC; Schiller T; DiCuccio M; Buehler PW; Ibla JC; Kimchi-Sarfaty C
Thromb Haemost; 2020 Dec; 120(12):1668-1679. PubMed ID: 32838472
[TBL] [Abstract][Full Text] [Related]
3. The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
Mancini I; Baronciani L; Artoni A; Colpani P; Biganzoli M; Cozzi G; Novembrino C; Boscolo Anzoletti M; De Zan V; Pagliari MT; Gualtierotti R; Aliberti S; Panigada M; Grasselli G; Blasi F; Peyvandi F
J Thromb Haemost; 2021 Feb; 19(2):513-521. PubMed ID: 33230904
[TBL] [Abstract][Full Text] [Related]
4. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Bauer F; Witzke O; Dittmer U; Bachmann M; Yilmaz S; Dittmer R; Schneppenheim S; Babel N; Budde U; Westhoff TH
Crit Care Med; 2021 May; 49(5):e512-e520. PubMed ID: 33591004
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.
Henry BM; Benoit SW; de Oliveira MHS; Lippi G; Favaloro EJ; Benoit JL
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):129-136. PubMed ID: 33270980
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
Joly BS; Darmon M; Dekimpe C; Dupont T; Dumas G; Yvin E; Beranger N; Vanhoorelbeke K; Azoulay E; Veyradier A
J Thromb Haemost; 2021 Sep; 19(9):2193-2198. PubMed ID: 34219357
[TBL] [Abstract][Full Text] [Related]
9. Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.
Grandone E; Vimercati A; Sorrentino F; Colaizzo D; Ostuni A; Ceci O; Capozza M; Tiscia G; De Laurenzo A; Mastroianno M; Cappucci F; Fischetti L; Margaglione M; Cicinelli E; Nappi L
BMC Pregnancy Childbirth; 2022 Feb; 22(1):142. PubMed ID: 35189860
[TBL] [Abstract][Full Text] [Related]
10. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
Akyol O; Akyol S; Chen CH
Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
[TBL] [Abstract][Full Text] [Related]
12. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.
Favaloro EJ; Henry BM; Lippi G
Semin Thromb Hemost; 2021 Jun; 47(4):400-418. PubMed ID: 33893632
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.
Delrue M; Siguret V; Neuwirth M; Joly B; Beranger N; Sène D; Chousterman BG; Voicu S; Bonnin P; Mégarbane B; Stépanian A
Br J Haematol; 2021 Mar; 192(6):1097-1100. PubMed ID: 33368196
[No Abstract] [Full Text] [Related]
14. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.
Yang J; Wu Z; Long Q; Huang J; Hong T; Liu W; Lin J
Front Immunol; 2020; 11():610696. PubMed ID: 33343584
[TBL] [Abstract][Full Text] [Related]
15. VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure.
Driever EG; Stravitz RT; Zhang J; Adelmeijer J; Durkalski V; Lee WM; Lisman T
Hepatology; 2021 May; 73(5):1882-1891. PubMed ID: 32767567
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
Marco A; Marco P
J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor: another janus-faced hemostasis protein.
Franchini M; Mannucci PM
Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
[TBL] [Abstract][Full Text] [Related]
18. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.
Turecek PL; Peck RC; Rangarajan S; Reilly-Stitt C; Laffan MA; Kazmi R; James I; Dushianthan A; Schrenk G; Gritsch H; Ewenstein BM; Mellgard B; Erdlenbruch W; Jain N; Binder NB; Mumford AD
Thromb Res; 2021 May; 201():100-112. PubMed ID: 33662796
[TBL] [Abstract][Full Text] [Related]
19. Laboratory testing for ADAMTS13: Utility for TTP diagnosis/exclusion and beyond.
Favaloro EJ; Pasalic L; Henry B; Lippi G
Am J Hematol; 2021 Aug; 96(8):1049-1055. PubMed ID: 33991361
[TBL] [Abstract][Full Text] [Related]
20. A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients.
Martín-Rojas RM; Chasco-Ganuza M; Casanova-Prieto S; Delgado-Pinos VE; Pérez-Rus G; Duque-González P; Sancho M; Díez-Martín JL; Pascual-Izquierdo C
Blood Coagul Fibrinolysis; 2021 Oct; 32(7):458-467. PubMed ID: 34310402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
